PubMed:17380205
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 98-125 | DiseaseOrPhenotypicFeature | denotes | Duchenne muscular dystrophy | 0010679 |
| T2 | 127-154 | DiseaseOrPhenotypicFeature | denotes | Duchenne muscular dystrophy | 0010679 |
| T3 | 156-159 | DiseaseOrPhenotypicFeature | denotes | DMD | 0010679 |
| T4 | 310-313 | DiseaseOrPhenotypicFeature | denotes | DMD | 0010679 |
| T5 | 591-594 | DiseaseOrPhenotypicFeature | denotes | DMD | 0010679 |
| T6 | 1058-1091 | DiseaseOrPhenotypicFeature | denotes | progression of muscular dystrophy | 0016106 |
| T7 | 1178-1181 | DiseaseOrPhenotypicFeature | denotes | DMD | 0010679 |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-126 | Sentence | denotes | Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. |
| T2 | 127-306 | Sentence | denotes | Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder associated with dystrophin deficiency that results in chronic inflammation and severe skeletal muscle degeneration. |
| T3 | 307-477 | Sentence | denotes | In DMD mouse models and patients, we find that IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling is persistently elevated in immune cells and regenerative muscle fibers. |
| T4 | 478-595 | Sentence | denotes | Ablation of 1 allele of the p65 subunit of NF-kappaB was sufficient to improve pathology in mdx mice, a model of DMD. |
| T5 | 596-860 | Sentence | denotes | In addition, conditional deletion of IKKbeta in mdx mice elucidated that NF-kappaB functions in activated macrophages to promote inflammation and muscle necrosis and in skeletal muscle fibers to limit regeneration through the inhibition of muscle progenitor cells. |
| T6 | 861-980 | Sentence | denotes | Furthermore, specific pharmacological inhibition of IKK resulted in improved pathology and muscle function in mdx mice. |
| T7 | 981-1182 | Sentence | denotes | Collectively, these results underscore the critical role of NF-kappaB in the progression of muscular dystrophy and suggest the IKK/NF-kappaB signaling pathway as a potential therapeutic target for DMD. |
| T1 | 0-126 | Sentence | denotes | Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. |
| T2 | 127-306 | Sentence | denotes | Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder associated with dystrophin deficiency that results in chronic inflammation and severe skeletal muscle degeneration. |
| T3 | 307-477 | Sentence | denotes | In DMD mouse models and patients, we find that IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling is persistently elevated in immune cells and regenerative muscle fibers. |
| T4 | 478-595 | Sentence | denotes | Ablation of 1 allele of the p65 subunit of NF-kappaB was sufficient to improve pathology in mdx mice, a model of DMD. |
| T5 | 596-860 | Sentence | denotes | In addition, conditional deletion of IKKbeta in mdx mice elucidated that NF-kappaB functions in activated macrophages to promote inflammation and muscle necrosis and in skeletal muscle fibers to limit regeneration through the inhibition of muscle progenitor cells. |
| T6 | 861-980 | Sentence | denotes | Furthermore, specific pharmacological inhibition of IKK resulted in improved pathology and muscle function in mdx mice. |
| T7 | 981-1182 | Sentence | denotes | Collectively, these results underscore the critical role of NF-kappaB in the progression of muscular dystrophy and suggest the IKK/NF-kappaB signaling pathway as a potential therapeutic target for DMD. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 207-217 | gene:1756 | denotes | dystrophin |
| T1 | 286-305 | disease:C0234958 | denotes | muscle degeneration |
| T2 | 207-217 | gene:1756 | denotes | dystrophin |
| T3 | 127-159 | disease:C0013264 | denotes | Duchenne muscular dystrophy (DMD |
| T4 | 506-509 | gene:65125 | denotes | p65 |
| T5 | 591-594 | disease:C0026850 | denotes | DMD |
| T6 | 506-509 | gene:5970 | denotes | p65 |
| T7 | 591-594 | disease:C0026850 | denotes | DMD |
| T8 | 506-509 | gene:6857 | denotes | p65 |
| T9 | 591-594 | disease:C0026850 | denotes | DMD |
| T10 | 506-509 | gene:64689 | denotes | p65 |
| T11 | 591-594 | disease:C0026850 | denotes | DMD |
| R1 | T0 | T1 | associated_with | dystrophin,muscle degeneration |
| R2 | T2 | T3 | associated_with | dystrophin,Duchenne muscular dystrophy (DMD |
| R3 | T4 | T5 | associated_with | p65,DMD |
| R4 | T6 | T7 | associated_with | p65,DMD |
| R5 | T8 | T9 | associated_with | p65,DMD |
| R6 | T10 | T11 | associated_with | p65,DMD |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 136-154 | HP_0003560 | denotes | muscular dystrophy |
| T2 | 173-181 | HP_0001417 | denotes | X-linked |
| T3 | 1073-1091 | HP_0003560 | denotes | muscular dystrophy |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 17380205-1#80#90#gene1756 | 207-217 | gene1756 | denotes | dystrophin |
| 17380205-1#0#27#diseaseC0013264 | 127-154 | diseaseC0013264 | denotes | Duchenne muscular dystrophy |
| 17380205-1#29#32#diseaseC0013264 | 156-159 | diseaseC0013264 | denotes | DMD |
| 17380205-1#159#178#diseaseC0234958 | 286-305 | diseaseC0234958 | denotes | muscle degeneration |
| 17380205-3#28#31#gene64689 | 506-509 | gene64689 | denotes | p65 |
| 17380205-3#28#31#gene5970 | 506-509 | gene5970 | denotes | p65 |
| 17380205-3#28#31#gene6857 | 506-509 | gene6857 | denotes | p65 |
| 17380205-3#28#31#gene65125 | 506-509 | gene65125 | denotes | p65 |
| 17380205-3#113#116#diseaseC0013264 | 591-594 | diseaseC0013264 | denotes | DMD |
| 80#90#gene17560#27#diseaseC0013264 | 17380205-1#80#90#gene1756 | 17380205-1#0#27#diseaseC0013264 | associated_with | dystrophin,Duchenne muscular dystrophy |
| 80#90#gene175629#32#diseaseC0013264 | 17380205-1#80#90#gene1756 | 17380205-1#29#32#diseaseC0013264 | associated_with | dystrophin,DMD |
| 80#90#gene1756159#178#diseaseC0234958 | 17380205-1#80#90#gene1756 | 17380205-1#159#178#diseaseC0234958 | associated_with | dystrophin,muscle degeneration |
| 28#31#gene64689113#116#diseaseC0013264 | 17380205-3#28#31#gene64689 | 17380205-3#113#116#diseaseC0013264 | associated_with | p65,DMD |
| 28#31#gene5970113#116#diseaseC0013264 | 17380205-3#28#31#gene5970 | 17380205-3#113#116#diseaseC0013264 | associated_with | p65,DMD |
| 28#31#gene6857113#116#diseaseC0013264 | 17380205-3#28#31#gene6857 | 17380205-3#113#116#diseaseC0013264 | associated_with | p65,DMD |
| 28#31#gene65125113#116#diseaseC0013264 | 17380205-3#28#31#gene65125 | 17380205-3#113#116#diseaseC0013264 | associated_with | p65,DMD |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1537 | 506-509 | gene:64689 | denotes | p65 |
| T1538 | 591-594 | disease:C0013264 | denotes | DMD |
| R1 | T1537 | T1538 | associated_with | p65,DMD |
| R2 | T1537 | T1538 | associated_with | p65,DMD |
| R3 | T1537 | T1538 | associated_with | p65,DMD |
| R4 | T1537 | T1538 | associated_with | p65,DMD |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-126 | Sentence | denotes | Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. |
| TextSentencer_T2 | 127-306 | Sentence | denotes | Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder associated with dystrophin deficiency that results in chronic inflammation and severe skeletal muscle degeneration. |
| TextSentencer_T3 | 307-477 | Sentence | denotes | In DMD mouse models and patients, we find that IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling is persistently elevated in immune cells and regenerative muscle fibers. |
| TextSentencer_T4 | 478-595 | Sentence | denotes | Ablation of 1 allele of the p65 subunit of NF-kappaB was sufficient to improve pathology in mdx mice, a model of DMD. |
| TextSentencer_T5 | 596-860 | Sentence | denotes | In addition, conditional deletion of IKKbeta in mdx mice elucidated that NF-kappaB functions in activated macrophages to promote inflammation and muscle necrosis and in skeletal muscle fibers to limit regeneration through the inhibition of muscle progenitor cells. |
| TextSentencer_T6 | 861-980 | Sentence | denotes | Furthermore, specific pharmacological inhibition of IKK resulted in improved pathology and muscle function in mdx mice. |
| TextSentencer_T7 | 981-1182 | Sentence | denotes | Collectively, these results underscore the critical role of NF-kappaB in the progression of muscular dystrophy and suggest the IKK/NF-kappaB signaling pathway as a potential therapeutic target for DMD. |
| T1 | 0-126 | Sentence | denotes | Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. |
| T2 | 127-306 | Sentence | denotes | Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder associated with dystrophin deficiency that results in chronic inflammation and severe skeletal muscle degeneration. |
| T3 | 307-477 | Sentence | denotes | In DMD mouse models and patients, we find that IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling is persistently elevated in immune cells and regenerative muscle fibers. |
| T4 | 478-595 | Sentence | denotes | Ablation of 1 allele of the p65 subunit of NF-kappaB was sufficient to improve pathology in mdx mice, a model of DMD. |
| T5 | 596-860 | Sentence | denotes | In addition, conditional deletion of IKKbeta in mdx mice elucidated that NF-kappaB functions in activated macrophages to promote inflammation and muscle necrosis and in skeletal muscle fibers to limit regeneration through the inhibition of muscle progenitor cells. |
| T6 | 861-980 | Sentence | denotes | Furthermore, specific pharmacological inhibition of IKK resulted in improved pathology and muscle function in mdx mice. |
| T7 | 981-1182 | Sentence | denotes | Collectively, these results underscore the critical role of NF-kappaB in the progression of muscular dystrophy and suggest the IKK/NF-kappaB signaling pathway as a potential therapeutic target for DMD. |